Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 11/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.65 |
| ▸ | MAPT | P10636 | 9/20 | 0.60 |
| ▸ | NPC1 | O15118 | 8/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.60 |
| ▸ | RAB9A | P51151 | 7/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.60 |
| ▸ | ATM | Q13315 | 2/20 | 0.60 |
| ▸ | TP53 | P04637 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | CASP1 | P29466 | 2/20 | 0.60 |
| ▸ | CASP7 | P55210 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | STAT1 | P42224 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3038573 | 0.87 | MEN1 (0.56) | MEN1KMT2AMAPTNPC1ALDH1A1 | |
| SCHEMBL3039249 | 0.82 | NPC1 (0.53) | MEN1KMT2AMAPTNPC1ALDH1A1 | |
| SCHEMBL3028821 | 0.82 | PPARG (0.46) | MEN1KMT2AMAPTNPC1ALDH1A1 | |
| SCHEMBL7047234 | 0.82 | MEN1 (0.79) | MEN1KMT2AMAPTNPC1ALDH1A1 | |
| SCHEMBL13298656 | 0.80 | KDM4E (0.55) | MEN1KMT2AMAPTNPC1ALDH1A1 | |
| SCHEMBL27627290 | 0.79 | PPARG (0.63) | MEN1KMT2AMAPTNPC1ALDH1A1 | |
| SCHEMBL14281089 | 0.79 | MEN1 (0.51) | MEN1KMT2AMAPTNPC1ALDH1A1 | |
| SCHEMBL27647508 | 0.79 | MAPT (0.56) | MEN1KMT2AMAPTNPC1ALDH1A1 | |
| SCHEMBL3040216 | 0.78 | NPC1 (0.53) | MEN1KMT2AMAPTNPC1ALDH1A1 | |
| SCHEMBL3216453 | 0.78 | RAB9A (0.58) | MEN1KMT2AMAPTNPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0925612-B1 | GALLIUM DOPED LITHIUM MANGANESE OXIDE SPINELS (LiGaxMn2-xO4) AS ACTIVE CATHODE MATERIAL FOR LITHIUM OR LITHIUM-ION RECHARGEABLE BATTERIES WITH IMPROVED CYCLING PERFORMANCE | CONSIGLIO NAZIONALE RICERCHE (IT) | 2000-09-13 | — | — | EP | claimed |
| JP-55125535-A | — | — | None | — | — | JP | disclosed |
| US-9182553-B2 | Optical switch activator with glowable member | COX, CHRISTOPHER E. | 2015-11-10 | — | — | US | disclosed |
| US-20140153869-A1 | Optical Switch Activator with Glowable Member | COX, CHRISTOPHER E. | 2014-06-05 | — | — | US | disclosed |
| US-8658962-B2 | Optical switch with glowable activator portion | COX, CHRISTOPHER E. | 2014-02-25 | — | — | US | disclosed |
| US-20130121637-A1 | Optical Switch Activator with Glowable Member | COX, CHRISTOPHER E. | 2013-05-16 | — | — | US | disclosed |
| US-8334501-B1 | Optical switch activator with glowable member | COX, CHRISTOPHER E. | 2012-12-18 | — | — | US | disclosed |
| US-7902989-B2 | Optical switch | COX, CHRISTOPHER E. | 2011-03-08 | — | — | US | disclosed |
| WO-2010093929-A1 | AN OPTICAL PRESSURE ACTIVATED DEVICE | COX RALEIGH L (US) | 2010-08-19 | — | — | WO | disclosed |
| US-20100168072-A1 | Drug Combinations for the Treatment of Duchenne Muscular Dystrophy | BIOMARIN IGA LIMITED | 2010-07-01 | — | — | US | disclosed |
| US-20100066548-A1 | Optical Switch | COX, CHRISTOPHER E. | 2010-03-18 | — | — | US | disclosed |
| US-20100048660-A1 | TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | BIOMARIN IGA LIMITED (BS) | 2010-02-25 | — | — | US | disclosed |
| EP-1986643-A1 | TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | Summit Corporation Plc (GB) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007091107-A1 | TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | SUMMIT CORPORATION PLC (GB) | 2007-08-16 | — | — | WO | disclosed |
| EP-0329573-B1 | DEVICE FOR AFFIXING A SINGLE OR MULTIPLE DOME, PARTICULARLY A SKYLIGHT OR VENTILATING SKYLIGHT | ECODIS (S.A.R.L.) (FR) | 1991-10-09 | — | — | EP | disclosed |
| EP-0329573-A1 | Device for affixing a single or multiple dome, particularly a skylight or ventilating skylight | ECODIS (S.A.R.L.) (FR) | 1989-08-23 | — | — | EP | disclosed |
| EP-0235660-A1 | Isocyanato-benzotriazoles and process for their preparation | BAYER AG (DE) | 1987-09-09 | — | — | EP | disclosed |
| JP-S55125535-A | TRANSFER MAGNETIC SHEET | HITACHI MAXELL LTD | 1980-09-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048660-A1 | TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | SMN1; SMN2, CPT1B, GYS1 | MEN1 2802/4885KMT2A 3534/4885MAPT 4772/4885 |
| US-20100168072-A1 | Drug Combinations for the Treatment of Duchenne Muscular Dystrophy | CPT1B, PYGM, MTPN | MEN1 3587/4885KMT2A 3863/4885MAPT 2870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.